128 related articles for article (PubMed ID: 29065740)
1. Budget impact analysis on the introduction of a guideline based hepatitis B and C screening into a routine check-up in the German primary care setting.
Barth C; Neusser S; Biermann J; Wasem J; Berg T; Wiegand J; Wolffram I; Petroff D; Aidelsburger P; Grünbauer A; Neumann A
Scand J Gastroenterol; 2018 Jan; 53(1):76-82. PubMed ID: 29065740
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of Access Expansion to Treatment of Hepatitis C Virus Infection Through Primary Care Providers.
Rattay T; Dumont IP; Heinzow HS; Hutton DW
Gastroenterology; 2017 Dec; 153(6):1531-1543.e2. PubMed ID: 29074450
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of hepatitis markers in immigrant populations: a prospective screening approach in a real-world setting.
Heidrich B; Cetindere A; Beyaz M; Stahmeyer JT; Basaran MM; Braynis B; Raupach R; Bremer B; Manns MP; Wedemeyer H; Bastürk M
Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1090-7. PubMed ID: 25076065
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.
Lin OS; Keeffe EB; Sanders GD; Owens DK
Aliment Pharmacol Ther; 2004 Jun; 19(11):1159-72. PubMed ID: 15153169
[TBL] [Abstract][Full Text] [Related]
5. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening.
Robotin MC; Kansil M; Howard K; George J; Tipper S; Dore GJ; Levy M; Penman AG
J Hepatol; 2009 May; 50(5):990-8. PubMed ID: 19303657
[TBL] [Abstract][Full Text] [Related]
6. Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective.
Veldhuijzen IK; Toy M; Hahné SJ; De Wit GA; Schalm SW; de Man RA; Richardus JH
Gastroenterology; 2010 Feb; 138(2):522-30. PubMed ID: 19879275
[TBL] [Abstract][Full Text] [Related]
7. Economic Analysis and Budget Impact of Tenofovir and Entecavir in the First-Line Treatment of Hepatitis B Virus in Italy.
Ruggeri M; Basile M; Coretti S; Drago C; Cicchetti A
Appl Health Econ Health Policy; 2017 Aug; 15(4):479-490. PubMed ID: 28197805
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness and budget impact analysis of facility-based screening and treatment of hepatitis C in Punjab state of India.
Chugh Y; Premkumar M; Grover GS; Dhiman RK; Teerawattananon Y; Prinja S
BMJ Open; 2021 Feb; 11(2):e042280. PubMed ID: 33589457
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital.
Qian MY; Yuwei J R; Angus P; Schelleman T; Johnson L; Gow P
J Gastroenterol Hepatol; 2010 May; 25(5):951-6. PubMed ID: 20546449
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
[TBL] [Abstract][Full Text] [Related]
11. The growing burden of liver cirrhosis: implications for preventive measures.
Wong MCS; Huang J
Hepatol Int; 2018 May; 12(3):201-203. PubMed ID: 29679258
[No Abstract] [Full Text] [Related]
12. Prevention could be less cost-effective than cure: the case of hepatitis C screening policies in France.
Loubière S; Rotily M; Moatti JP
Int J Technol Assess Health Care; 2003; 19(4):632-45. PubMed ID: 15095769
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of screening immigrants for hepatitis B.
Wong WW; Woo G; Jenny Heathcote E; Krahn M
Liver Int; 2011 Sep; 31(8):1179-90. PubMed ID: 21745300
[TBL] [Abstract][Full Text] [Related]
14. [The natural course of hepatitis B and hepatitis C virus infection].
Schwabe RF; Stremmel W
Praxis (Bern 1994); 1998 Oct; 87(42):1403-7. PubMed ID: 9824947
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of a two-stage screening intervention for hepatocellular carcinoma in Taiwan.
Shih ST; Crowley S; Sheu JC
J Formos Med Assoc; 2010 Jan; 109(1):39-55. PubMed ID: 20123585
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States.
Chhatwal J; Kanwal F; Roberts MS; Dunn MA
Ann Intern Med; 2015 Mar; 162(6):397-406. PubMed ID: 25775312
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of screening for hepatocellular carcinoma among subjects at different levels of risk.
Chang Y; Lairson DR; Chan W; Lu SN; Aoki N
J Eval Clin Pract; 2011 Apr; 17(2):261-7. PubMed ID: 20874834
[TBL] [Abstract][Full Text] [Related]
18. A cost-consequence analysis of hepatitis B screening in an immigrant population.
Buja A; Martines D; Lobello S; Vinelli A; Bardelle G; Lopatriello S; De Lazzari F; Perrier L; Baldo V
Ann Ist Super Sanita; 2015; 51(4):327-35. PubMed ID: 26783220
[TBL] [Abstract][Full Text] [Related]
19. Public health impact of comprehensive hepatitis C screening and treatment in the French baby-boomer population.
Ethgen O; Sanchez Gonzalez Y; Jeanblanc G; Duguet A; Misurski D; Juday T
J Med Econ; 2017 Feb; 20(2):162-170. PubMed ID: 27590836
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of universal hepatitis B virus screening in patients beginning chemotherapy for solid tumors.
Day FL; Karnon J; Rischin D
J Clin Oncol; 2011 Aug; 29(24):3270-7. PubMed ID: 21788556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
